Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor

Blood

Volumn 88, Issue 9, 1996, Pages 3323-3328

  Weaver, A ^a   Ryder, D ^b   Crowther, D ^b   Dexter, T M ^b   Testa, N G ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING CELL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029907128     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3323.bloodjournal8893323     Document Type: Article

References (39)

1. Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral blood of mice. Blood 19:702, 1962
2. Epstein RB, Graham TC, Buckner CD: Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. Blood 28:692, 1966
3. Storb R, Graham TC, Epstein RB, Sale GE, Thomas ED: Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 50:537, 1977
4. Abrams RA, Glaubiger D, Appelbaum FR, Deisseroth AB: Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells. A case report. Blood 56:516, 1980
5. McCredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171:293, 1971
6. Chervenick PA, Boggs DR: In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. Blood 37:131, 1971
7. Clarke BJ, Housman D: Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood. Proc Natl Acad Sci USA 74:1105, 1977
8. Duhrsen U, Villeval J-L, Boyd J, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hemopoietic cells in cancer patients. Blood 72:2074, 1988
9. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral blood progenitor cells mobilised by G-CSF (filgrastim) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
10. Demuynck H, Pettengel R, De Campos ES, Dexter TM, Testa NG: The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is comparable to that of bone marrow. Eur J Cancer 28:381, 1992
11. Korbling M, Dorken B, Ho AD, Pezzutto A, Hunstein W, Fliedner TM: Autologous transplantation of blood-derived hematopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 67:529, 1986
12. Reiffers J, Bernard P, David B, Vezon G, Sarrat A, Marit G, Moulinier J, Broustet A: Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 14:312, 1986
13. Juttner CA, To LB, Ho JQK, Bardy PG, Dyson PG, Haylock DN, Kimber RJ: Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute nonlymphoblastic leukemia. Transplant Proc 20:40, 1988
14. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723, 1988
15. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
16. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hemopoietic cells in long term cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
17. Breems DA, Blokland EA, Neben S, Ploemacher RE: Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8:1095, 1994
18. Ploemacher RE, Van der Sluijs JP, Voerman JSA, Brons NHC: An in vitro limiting dilution assay of long term repopulating hematopoietic stem cells in the mouse. Blood 74:2755, 1989
19. Ploemacher RE, Van der Sluijs JP, Van Beurden CAJ, Baert MRM, Chan PL: Use of limiting dilution assay of long term marrow cultures in frequency analysis of marrow repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78:2527, 1991
20. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
21. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715, 1992
22. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
23. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsdon M, Fausset P, Myerson D, Appelbaum FR, McNiece IK: Low dose recombinant human stem cell factor (SCF) has a synergistic interaction with recombinant human granulocyte colony-stimulating factor (G-CSF) in vivo for stimulating the circulation of progenitor cells of multiple types in peripheral blood of baboons. Blood 82:232a, 1993 (abstr, suppl 1)
24. De Revel T, Applebaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece IK, Andrews RG, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
25. Glaspy J, LeMaistre CF, Lill M, Jones R, Moore A, Briddell RA, Menchaca D, Turner S, Shpall EJ: Dose response of 7 day administration of recombinant methionyl human stem cell factor (SCF) in combination with filgrastim (G-CSF) for progenitor cell mobilization in patients with stage II-IV breast cancer. Blood 86:1837, 1995
26. Weaver A, Slowley C, Woll PJ, Lind M, Jenkins B, Gill C, Wilkinson PM, Dexter TM, Testa NG, Crowther D: A randomised comparison of progenitor cell mobilization using chemotherapy plus stem cell factor (r-metHuSCF) and filgrastim (r-metHuG-CSF) or chemotherapy plus filgrastim. Proc Am Soc Clin Oncol 15:269, 1996
27. Pettengell R, Luft T, Henschler R, Hows J, Dexter TM, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long term culture-initiating cells in human bone marrow, umbilical cord blood and blood stem cells. Blood 84:3653, 1994
28. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991
29. Fazekas de St Groth S: The evaluation of limiting dilution assays. J Immunol Methods 49:R11, 1982
30. Anderson DA, Aitkin M: Variance component models with binary response:interviewer variability. J R Stat Soc 47:203, 1985
31. - progenitor cells. Blood 77:1218, 1991
32. + bone marrow cells. Blood 84:1473, 1994
33. Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ: Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513, 1992
34. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE: Kinetics of committed and primitive blood progenitor cell mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 83:3808, 1994
35. Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Vonn dem Borne AE, van der School CE: Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation. J Clin Oncol 13:1922, 1995
36. Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R, Serke S, Huhn D: Autografting with blood progenitor cells: Predictive value of prepheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hermitopoietic reconstitution. Ann Hematol 71:227, 1995
37. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
38. Peters WP, Rosner G, Ross M: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709, 1993
39. Weaver A, Testa NG: Comparison of endpoints in long term initiating cell cultures using limiting dilution. Proceedings of the Fourth International Symposium on Blood Cell Transplantation. Adelaide, Australia, March 1996, p 72